Targeted therapies are used in patients with a set gene expression pattern. A targeted therapy that prevents the activation of the estrogen receptor in breast cancer would be beneficial to which type of patient?
Patients who express the EGFR receptor in normal cells
Patients that have no estrogen receptor expressed in their tumor
Patients with a mutation that inactivates the estrogen receptor
Patients with lots of the estrogen receptor expressed in their tumorCorrect